Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page history now shows a new revision entry (v3.3.4) and the previous revision (v3.3.3) has been removed, reflecting a minor update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:20:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:18:23.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision label on the header updated from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:18.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.3.1 and removed Revision: v3.2.0 from the record history of NCT03794544. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:37:20.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The government funding operating status notice was removed from the page. The rest of the study history and related content remains unchanged.
    Difference
    0.5%
    Check dated 2025-11-17T06:48:43.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A new version entry (23) was added to the record history on 2022-02-23. It updates the Study Status and related documentation.
    Difference
    0.1%
    Check dated 2025-11-03T01:15:12.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.